Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Aug 30;26(17):8446.
doi: 10.3390/ijms26178446.

Recent Advances in Anti-Cancer Drugs

Affiliations
Editorial

Recent Advances in Anti-Cancer Drugs

Christiana M Neophytou. Int J Mol Sci. .

Abstract

Despite the significant advancements in anti-cancer research in the last two decades, the development of anti-cancer therapeutics remains a central focus in oncology [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Ma H.Y., Das J., Prendergast C., De Jong D., Braumuller B., Paily J., Huang S., Liou C., Giarratana A., Hosseini M., et al. Advances in CAR T Cell Therapy for Non-Small Cell Lung Cancer. Curr. Issues Mol. Biol. 2023;45:9019–9038. doi: 10.3390/cimb45110566. - DOI - PMC - PubMed
    1. Min H.Y., Lee H.Y. Molecular targeted therapy for anticancer treatment. Exp. Mol. Med. 2022;54:1670–1694. doi: 10.1038/s12276-022-00864-3. - DOI - PMC - PubMed
    1. Bashraheel S.S., Domling A., Goda S.K. Update on targeted cancer therapies, single or in combination, and their fine tuning for precision medicine. Biomed. Pharmacother. 2020;125:110009. doi: 10.1016/j.biopha.2020.110009. - DOI - PubMed
    1. Liu B., Zhou H., Tan L., Siu K.T.H., Guan X.Y. Exploring treatment options in cancer: Tumor treatment strategies. Signal Transduct. Target. Ther. 2024;9:175. doi: 10.1038/s41392-024-01856-7. - DOI - PMC - PubMed
    1. Hou J., He Z., Liu T., Chen D., Wang B., Wen Q., Zheng X. Evolution of Molecular Targeted Cancer Therapy: Mechanisms of Drug Resistance and Novel Opportunities Identified by CRISPR-Cas9 Screening. Front. Oncol. 2022;12:755053. doi: 10.3389/fonc.2022.755053. - DOI - PMC - PubMed

Publication types

Substances

LinkOut - more resources